| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/30/2007 | US7169606 Lyophilization of human platelets |
| 01/30/2007 | US7169594 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 01/30/2007 | US7169580 Protein having PGE2 synthase activity and use thereof |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/30/2007 | US7169409 Heating film or laminate of a transdermal delivery device which comprises a dispersion of liquid drug in a matrix immediately following film formation or lamination; maintaining heat; cooling |
| 01/30/2007 | US7169407 Carbonyl stress-decreasing agent |
| 01/30/2007 | US7169392 Vaccine complex; forming antibodies |
| 01/30/2007 | US7169390 Administering an agent binds a sphingolipid or a sphingolipid metabolite, especially an antibody or derivative, a receptor of a sphingolipid or a sphingolipid metabolite. |
| 01/30/2007 | US7169385 Solubilized CoQ-10 and carnitine |
| 01/30/2007 | US7169381 Aqueous solution of polyoxyethylene glycol , ascorbic acid and electrolyte |
| 01/30/2007 | US7169379 Cosmetics |
| 01/30/2007 | US7169378 Delivery of opioids through an inhalation route |
| 01/30/2007 | US7169359 Bioequivalence test for iron-containing formulations |
| 01/30/2007 | US7168597 Aerosol metering valve |
| 01/30/2007 | CA2484115C Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 01/30/2007 | CA2468771C Pharmaceutical composition for use in ophthalmology and rhinology |
| 01/30/2007 | CA2440383C 7,9-substituted tetracycline compounds |
| 01/30/2007 | CA2411153C Method for preparing a composition |
| 01/30/2007 | CA2394861C N6 heterocyclic 8-modified adenosine derivatives |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/30/2007 | CA2307551C Pleuromutilin derivatives as antimicrobials |
| 01/30/2007 | CA2302411C Improved method for preventing crystal formation in a scopolamine transdermal device |
| 01/30/2007 | CA2302017C Prevention of adhesions and excessive scar formation using angiogenesis inhibitors |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/30/2007 | CA2289623C A new process for the preparation of a pharmacologically active substance |
| 01/30/2007 | CA2286723C Tricyclic compounds |
| 01/30/2007 | CA2266401C Use of sibutramine analogues to prevent the development of diabetes |
| 01/30/2007 | CA2265615C Reflux inhibitors |
| 01/30/2007 | CA2260841C Methods of preventing skeletal problems in poultry |
| 01/30/2007 | CA2260060C Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 01/30/2007 | CA2257235C Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity |
| 01/30/2007 | CA2255226C Use of cinnamic acid, or at least of one of its derivatives, in a cosmetic composition |
| 01/30/2007 | CA2251002C Estradiol and progesterone-based medicament |
| 01/30/2007 | CA2236545C 4,10.beta.-diacetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1-hydroxy-9-ox0-19-nor-cyclopropa[g]tax-11-ene-13.alpha.-yl (2r,3s)-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionatedihydrate, and method for preparing same |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/30/2007 | CA2226886C N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 01/30/2007 | CA2214322C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 01/30/2007 | CA2173208C Levobupivacaine useful for managing chronic pain |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/30/2007 | CA2166704C Arsenic medicaments for the treatment of chronic fatigue syndrome |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/30/2007 | CA2163363C Stable suppository formulations effecting biovailability of .delta.9-thc |
| 01/30/2007 | CA2154098C Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 01/30/2007 | CA2126917C New n-phenyl 2-cyano 3-hydroxy propenamides; tautomers and salts thereof; process for preparing them and their use as therapeutic agents; compositions containing these new product |
| 01/29/2007 | CA2554737A1 Compositions and methods for treating cancer and other diseases characterized by abnormal cell proliferation |
| 01/29/2007 | CA2554394A1 System for treating aneurysmal disease |
| 01/29/2007 | CA2514381A1 Improved topical preparation and method for using same to destroy herpes simplex cells |
| 01/28/2007 | CA2552831A1 Polysubstitute 1,1-pyridinylaminocyclopropanamine compounds, the process for preparing them and the pharmaceutical formulations that contain them |
| 01/28/2007 | CA2552827A1 Polysubstitute 1-1-pyridinyloxycyclopropanamine compounds, the process for preparing them and the pharmaceutical formulations that contain them |
| 01/27/2007 | CA2518844A1 Stabilized pharmaceutical and cosmetic composition of catechins or derivatives thereof |
| 01/25/2007 | WO2008030217A2 Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers |
| 01/25/2007 | WO2007012075A2 Preparation of montelukast |
| 01/25/2007 | WO2007012064A2 Prevention and treatment of hearing disorders |
| 01/25/2007 | WO2007012042A1 New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide |
| 01/25/2007 | WO2007012022A2 Unit dose form with ibuprofen-famotidine admixture |
| 01/25/2007 | WO2007012019A2 Medicaments containing famotidine and ibuprofen and administration of same |
| 01/25/2007 | WO2007011972A2 Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
| 01/25/2007 | WO2007011967A2 Method of using click chemistry to functionalize dendrimers |
| 01/25/2007 | WO2007011962A2 Treatment of cancer |
| 01/25/2007 | WO2007011955A2 Drug-containing implants and methods of use thereof |
| 01/25/2007 | WO2007011940A2 Sustained release of antiinfectives |
| 01/25/2007 | WO2007011926A2 Methods for treating and diagnosing complications of premature birth |
| 01/25/2007 | WO2007011905A2 Lpa2 receptor agonist inhibitors of cftr |
| 01/25/2007 | WO2007011886A2 Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof |
| 01/25/2007 | WO2007011835A2 Antiarrhythmic precursor compounds, methods of synthesis and methods of use |
| 01/25/2007 | WO2007011833A2 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/25/2007 | WO2007011820A2 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/25/2007 | WO2007011811A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011810A1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/25/2007 | WO2007011809A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011802A1 Method for preparing branched functionalized polymers using branched polyol cores |
| 01/25/2007 | WO2007011764A2 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 01/25/2007 | WO2007011762A2 Jnk inhibitors for the treatment of endometreosis |
| 01/25/2007 | WO2007011760A2 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011743A2 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
| 01/25/2007 | WO2007011740A2 A powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis |
| 01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011720A2 Cyclopentane n-lower alkyl heptenamide-5-cis-2- (3alapha- hydroxy-5-phenylpentyl) -3, ?5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure |
| 01/25/2007 | WO2007011702A2 Use of egfr inhibitors to prevent or treat obesity |
| 01/25/2007 | WO2007011701A1 Novel hydrochloride salts of levodopa |
| 01/25/2007 | WO2007011699A2 Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores |
| 01/25/2007 | WO2007011674A2 Compositions and methods for treating and preventing inflammatory and/or degenerative processes in humans and other animals |
| 01/25/2007 | WO2007011658A1 Antiviral compounds |
| 01/25/2007 | WO2007011629A2 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 01/25/2007 | WO2007011623A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | WO2007011618A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | WO2007011601A2 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 01/25/2007 | WO2007011594A2 Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof |
| 01/25/2007 | WO2007011575A2 Method and composition for bone growth |
| 01/25/2007 | WO2007011574A1 Solvent-free, self-polishing polyurethane matrix for use in solvent-free antifoulings |
| 01/25/2007 | WO2007011563A1 Derivatives of seleno-amino acids |
| 01/25/2007 | WO2007011504A1 Breath freshening and oral cleansing product comprising a magnolia bark extract and surfactant |
| 01/25/2007 | WO2007011349A1 Novel granulation process and granulate produced therefrom |
| 01/25/2007 | WO2007011293A1 Novel piperidine derivatives |
| 01/25/2007 | WO2007011292A1 N-benzyl-morpholine derivatives as modulators of the chemokine receptor |
| 01/25/2007 | WO2007011290A1 Bronchorelaxing agents based on indol- and isoquinoline derivatives |
| 01/25/2007 | WO2007011286A1 Therapeutic agents |
| 01/25/2007 | WO2007011285A1 Therapeutic agents |